Home Newsfeeds Needham Reiterates Buy on CompoSecure, Maintains $15 Price Target

Needham Reiterates Buy on CompoSecure, Maintains $15 Price Target

Needham analyst John Todaro reiterates CompoSecure (NASDAQ:CMPO) with a Buy and maintains $15 price target.

byBenzinga Newsdesk

March 2, 2023

1 minute read

Needham analyst John Todaro reiterates CompoSecure (NASDAQ:CMPO) with a Buy and maintains $15 price target.

SVB Leerink Maintains Outperform on Veeva Sys, Lowers Price Target to $242

By Benzinga Newsdesk

September 1, 5:24 AM

SVB Leerink analyst Stephanie Davis maintains Veeva Sys (NYSE:VEEV) with a Outperform and lowers the price target from $268 to $242.

VEEV

‘”Vice News Tonight” To Go Off The Air As Company Cuts Jobs; The Company Expects To Cut More Than 100 Jobs As Part Of The Broader Reorganization” – CNN

By Happy Mohamed

April 27, 11:59 AM

https://www.cnn.com/2023/04/27/media/vice-news-tonight-canceled/index.html Vice Media will cancel its acclaimed program “Vice News Tonight” as part of a broad restructuring that will result in painful

DIS

News

Tesla Plans To Build 1.6M Model Y And Model 3’s Globally In The First Three Quarters In 2023; Tesla Plans To Produce 495,000 Model Y, Model 3’s Globally In Q4, Sharply Higher Than Q3 – Sources

By Benzinga Newsdesk

September 30, 11:07 AM

- Reuters

TSLA

MyMD Pharmaceuticals And Charles River Present Data For Next Generation, Oral TNF-α Inhibitor MYMD-1 In Rheumatoid Arthritis

By Happy Mohamed

March 20, 8:55 AM

Preclinical results showed MYMD-1® significantly reduced histopathological changes and the severity of standard arthritis clinical trial measures compared to placebo; demonstrate future potential to disrupt the TNF-α inhibitor market

CRL

Needham Reiterates Buy on CompoSecure, Maintains $15 Price Target

Related Posts

SVB Leerink Maintains Outperform on Veeva Sys, Lowers Price Target to $242

‘”Vice News Tonight” To Go Off The Air As Company Cuts Jobs; The Company Expects To Cut More Than 100 Jobs As Part Of The Broader Reorganization” – CNN

Tesla Plans To Build 1.6M Model Y And Model 3’s Globally In The First Three Quarters In 2023; Tesla Plans To Produce 495,000 Model Y, Model 3’s Globally In Q4, Sharply Higher Than Q3 – Sources

MyMD Pharmaceuticals And Charles River Present Data For Next Generation, Oral TNF-α Inhibitor MYMD-1 In Rheumatoid Arthritis